Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Demyelination is a pathological feature commonly observed in various central nervous system diseases. It is characterized by the aggregation of oligodendrocyte progenitor cells (OPCs) in the lesion area, which face difficulties in differentiating into mature oligodendrocytes (OLGs). The differentiation of OPCs requires the presence of Sox10, but its expression decreases under pathological conditions. Therefore, we propose a therapeutic strategy to regulate OPCs differentiation and achieve myelin repair by endogenously loading Sox10 into exosomes. To accomplish this, we generated a lentivirus-armed Sox10 that could anchor to the inner surface of the exosome membrane. We then infected HEK293 cells to obtain exosomes with high expression of Sox10 (exosomes-Sox10, ExoSs). In vitro, experiments confirmed that both Exos and ExoSs can be uptaken by OPCs, but only ExoSs exhibit a pro-differentiation effect on OPCs. In vivo, we administered PBS, Exos, and ExoSs to cuprizone-induced demyelinating mice. The results demonstrated that ExoSs can regulate the differentiation of PDGFRα+ OPCs into APC+ OLGs and reduce myelin damage in the corpus callosum region of the mouse brain compared to other groups. Further testing suggests that Sox10 may have a reparative effect on the myelin sheath by enhancing the expression of MBP, possibly facilitated by the exosome delivery of the protein into the lesion. This endogenously loaded technology holds promise as a strategy for protein-based drugs in the treatment of demyelinating diseases. Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Citation

Jin He, Yan Wang, Zhuo-Hua Zhao, Jia-Yi He, Meng-Yuan Gao, Jia-Qi Wang, Li-Bin Wang, Yuan Zhang, Xing Li. Exosome-specific loading Sox10 for the treatment of Cuprizone-induced demyelinating model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024 Feb;171:116128

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38218078

View Full Text